BACKGROUND AND OBJECTIVE: The acceptability of financial incentives for organ donation is contentious. This study sought to determine (1) the acceptability of expense reimbursement or financial incentives by the general public, health professionals involved with organ donation and transplantation, and those with or affected by kidney disease and (2) for the public, whether financial incentives would alter their willingness to consider donation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Web-based survey administered to members of the Canadian public, health professionals, and people with or affected by kidney disease asking questions regarding acceptability of strategies to increase living and deceased kidney donation and willingness to donate a kidney under various financial incentives. RESULTS: Responses were collected from 2004 members of the Canadian public October 11-18, 2011; responses from health professionals (n=339) and people with or affected by kidney disease (n=268) were collected during a 4-week period commencing October 11, 2011. Acceptability of one or more financial incentives to increase deceased and living donation was noted in >70% and 40% of all groups, respectively. Support for monetary payment for living donors was 45%, 14%, and 27% for the public, health professionals, and people with or affected by kidney disease, respectively. Overall, reimbursement of funeral expenses for deceased donors and a tax break for living donors were the most acceptable. CONCLUSION: The general public views regulated financial incentives for living and deceased donation to be acceptable. Future research needs to examine the impact of financial incentives on rates of deceased and living donors.
BACKGROUND AND OBJECTIVE: The acceptability of financial incentives for organ donation is contentious. This study sought to determine (1) the acceptability of expense reimbursement or financial incentives by the general public, health professionals involved with organ donation and transplantation, and those with or affected by kidney disease and (2) for the public, whether financial incentives would alter their willingness to consider donation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Web-based survey administered to members of the Canadian public, health professionals, and people with or affected by kidney disease asking questions regarding acceptability of strategies to increase living and deceased kidney donation and willingness to donate a kidney under various financial incentives. RESULTS: Responses were collected from 2004 members of the Canadian public October 11-18, 2011; responses from health professionals (n=339) and people with or affected by kidney disease (n=268) were collected during a 4-week period commencing October 11, 2011. Acceptability of one or more financial incentives to increase deceased and living donation was noted in >70% and 40% of all groups, respectively. Support for monetary payment for living donors was 45%, 14%, and 27% for the public, health professionals, and people with or affected by kidney disease, respectively. Overall, reimbursement of funeral expenses for deceased donors and a tax break for living donors were the most acceptable. CONCLUSION: The general public views regulated financial incentives for living and deceased donation to be acceptable. Future research needs to examine the impact of financial incentives on rates of deceased and living donors.
Authors: M C van Buren; E K Massey; L Maasdam; W C Zuidema; M T Hilhorst; J N Ijzermans; W Weimar Journal: Am J Transplant Date: 2010-11 Impact factor: 8.086
Authors: Walter D Park; Joseph P Grande; Dora Ninova; Karl A Nath; Jeffrey L Platt; James M Gloor; Mark D Stegall Journal: Am J Transplant Date: 2003-08 Impact factor: 8.086
Authors: Allison Tong; Angelique F Ralph; Jeremy R Chapman; Germaine Wong; John S Gill; Michelle A Josephson; Jonathan C Craig Journal: Clin J Am Soc Nephrol Date: 2015-04-23 Impact factor: 8.237
Authors: James R Rodrigue; Aaron Fleishman; Michaela Carroll; Amy R Evenson; Martha Pavlakis; Didier A Mandelbrot; Prabhakar Baliga; David H Howard; Jesse D Schold Journal: Curr Transplant Rep Date: 2018-01-19
Authors: Giorgina Barbara Piccoli; Laura Sacchetti; Laura Verzè; Franco Cavallo Journal: Philos Ethics Humanit Med Date: 2015-12-18 Impact factor: 2.464
Authors: Kyla L Naylor; Susan McKenzie; Cindy Cherry; Eric McArthur; Alvin H Li; Megan K McCallum; S Joseph Kim; Versha Prakash; Gregory A Knoll; Amit X Garg Journal: Can J Kidney Health Dis Date: 2017-07-05